These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 12615790)

  • 1. Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure.
    Yokoe T; Minoguchi K; Matsuo H; Oda N; Minoguchi H; Yoshino G; Hirano T; Adachi M
    Circulation; 2003 Mar; 107(8):1129-34. PubMed ID: 12615790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated production of tumor necrosis factor-alpha by monocytes in patients with obstructive sleep apnea syndrome.
    Minoguchi K; Tazaki T; Yokoe T; Minoguchi H; Watanabe Y; Yamamoto M; Adachi M
    Chest; 2004 Nov; 126(5):1473-9. PubMed ID: 15539715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum Romo1 is significantly associated with disease severity in patients with obstructive sleep apnea syndrome.
    Ye L; Qian Y; Li Q; Fang S; Yang Z; Tan Y; Gu W
    Sleep Breath; 2018 Sep; 22(3):743-748. PubMed ID: 29302924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of continuous positive airway pressure (CPAP) therapy on IL-23 in patients with obstructive sleep apnea.
    Can M; Uygur F; Tanrıverdi H; Acıkgoz B; Alper B; Guven B
    Immunol Res; 2016 Dec; 64(5-6):1179-1184. PubMed ID: 27665460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute effect of nasal continuous positive airway pressure therapy on the systemic immunity of patients with obstructive sleep apnea syndrome.
    Nakamura T; Chin K; Shimizu K; Kita H; Mishima M; Nakamura T; Ohi M
    Sleep; 2001 Aug; 24(5):545-53. PubMed ID: 11480652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Long term effect of autoadjusting positive airway pressure on C-reactive protein and interleukin-6 in men with obstructive sleep apnoea syndrome].
    Drummond M; Winck J; Guimarães J; Santos AC; Almeida J; Marques J
    Arch Bronconeumol; 2009 Dec; 45(12):577-84. PubMed ID: 19552994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of nasal continuous positive airway pressure on vascular functions and serum cardiovascular risk factors in obstructive sleep apnea syndrome.
    Chung S; Yoon IY; Lee CH; Kim JW
    Sleep Breath; 2011 Jan; 15(1):71-6. PubMed ID: 20084550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of obstructive sleep apnea on circulating ICAM-1, IL-8, and MCP-1.
    Ohga E; Tomita T; Wada H; Yamamoto H; Nagase T; Ouchi Y
    J Appl Physiol (1985); 2003 Jan; 94(1):179-84. PubMed ID: 12391099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of nasal continuous positive airway pressure treatment on plasma adrenomedullin levels in patients with obstructive sleep apnea syndrome: roles of nocturnal hypoxia and oxidant stress.
    Yamamoto H; Teramoto S; Yamaguchi Y; Ouchi Y
    Hypertens Res; 2007 Nov; 30(11):1065-76. PubMed ID: 18250556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular risk markers in obstructive sleep apnoea syndrome and correlation with obesity.
    Ryan S; Nolan GM; Hannigan E; Cunningham S; Taylor C; McNicholas WT
    Thorax; 2007 Jun; 62(6):509-14. PubMed ID: 17251313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased levels and activity of matrix metalloproteinase-9 in obstructive sleep apnea syndrome.
    Tazaki T; Minoguchi K; Yokoe T; Samson KT; Minoguchi H; Tanaka A; Watanabe Y; Adachi M
    Am J Respir Crit Care Med; 2004 Dec; 170(12):1354-9. PubMed ID: 15361365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated C-reactive protein levels and increased cardiovascular risk in patients with obstructive sleep apnea syndrome.
    Kokturk O; Ciftci TU; Mollarecep E; Ciftci B
    Int Heart J; 2005 Sep; 46(5):801-9. PubMed ID: 16272771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in inflammatory mediators as a result of intermittent hypoxia in obstructive sleep apnea syndrome.
    Sozer V; Kutnu M; Atahan E; Calıskaner Ozturk B; Hysi E; Cabuk C; Musellim B; Simsek G; Uzun H
    Clin Respir J; 2018 Apr; 12(4):1615-1622. PubMed ID: 28960823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between Interleukin-6 and vitamin D serum levels in patients with obstructive sleep apnea syndrome and impact of long-term continuous positive airway pressure therapy on biomarker levels.
    Kotsiou OS; Siachpazidou DI; Pastaka C; Gogou E; Stavrou V; Kechagia M; Varsamas C; Hatzoglou C; Gourgoulianis KI
    Respir Physiol Neurobiol; 2022 Feb; 296():103806. PubMed ID: 34678476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of obesity and obstructive sleep apnea on metabolic hormones.
    Sánchez-de-la-Torre M; Mediano O; Barceló A; Piérola J; de la Peña M; Esquinas C; Miro A; Durán-Cantolla J; Agustí AG; Capote F; Marin JM; Montserrat JM; García-Río F; Barbé F
    Sleep Breath; 2012 Sep; 16(3):649-56. PubMed ID: 21912907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between inflammatory factors and arrhythmia and heart rate variability in OSAS patients.
    Xie JY; Liu WX; Ji L; Chen Z; Gao JM; Chen W; Chen GF; Zhu Q
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):2037-2053. PubMed ID: 32141573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term effects of nasal continuous positive airway pressure on vasodilatory endothelial function in obstructive sleep apnea syndrome.
    Duchna HW; Orth M; Schultze-Werninghaus G; Guilleminault C; Stoohs RA
    Sleep Breath; 2005 Sep; 9(3):97-103. PubMed ID: 16021522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Appropriate use of nasal continuous positive airway pressure decreases elevated C-reactive protein in patients with obstructive sleep apnea.
    Ishida K; Kato M; Kato Y; Yanagihara K; Kinugasa Y; Kotani K; Igawa O; Hisatome I; Shigemasa C; Somers VK
    Chest; 2009 Jul; 136(1):125-129. PubMed ID: 19255295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased serum levels of C-reactive protein and matrix metalloproteinase-9 in obstructive sleep apnea syndrome.
    Ye J; Liu H; Li Y; Liu X; Zhu JM
    Chin Med J (Engl); 2007 Sep; 120(17):1482-6. PubMed ID: 17908454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of nasal continuous positive airway pressure short-term treatment on C-reactive protein and intercellular adhesion molecule-1 in patients with obstructive sleep apnea-hypopnea syndrome].
    Wang YN; Yang Y; Luo YQ; Chen LL
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Dec; 30(6):666-9. PubMed ID: 16708805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.